Table 1.
Cohort Characteristics.
| Sample Group | CT | AsymAD | AD |
|---|---|---|---|
| Sample Size | N = 133 | N = 127 | N = 130 |
| Characteristics | |||
| Sex | 99 F, 34 M | 94 F, 33 M | 97 F, 33 M |
| Agea | 66 ± 6 | 66 ± 6 | 66 ± 6 |
| MoCAb | 26.8 ± 2.0 | 26.4 ± 2.6 | 17.4 ± 5.5 |
| CSF Aβ42b | 1394.0 ± 280.7 | 752.0 ± 238.2 | 587.0 ± 236.8 |
| CSF tTaub | 165.8 ± 35.0 | 260.8 ± 97.2 | 375.7 ± 139.6 |
| CSF pTaub | 14.7 ± 3.2 | 25.2 ± 11.1 | 38.5 ± 15.5 |
aAge in years. Values given as average ± standard deviation.
bMoCA, CSF Aβ42, CSF tTau, and CSF pTau in pg/mL. Values given in average ± standard deviation.
Abbreviations: CT, Control; AD, Alzheimer’s disease; MoCA, Montreal Cognitive Assessment.